Latest Breaking News On - Primary biliary cholangitis - Page 1 : comparemela.com

Science 37 Surpasses Enrollment Goals, Accelerates Phase 2 Rare Disease Clinical Trial

Science 37 Enrolls 21% of Study Participants at 11x the Speed of Traditional Research Sites Through its Virtual Site and Patient Recruitment Solutions RESEARCH…

Erica-prowisor
Provider-networks-at-science
Holdings-inc
Speed-of-traditional-research-sites
Patient-recruitment-solutions
Study-participants
Traditional-research-sites-through
Virtual-site
Patient-recruitment
Cholestatic-pruritus
Primary-biliary-cholangitis
Primary-sclerosing

GENFIT: Historic Milestone Achieved with U.S. FDA Accelerated Approval of Ipsen's Iqirvo® for Primary Biliary Cholangitis | 10.06.24

GENFIT: Historic Milestone Achieved with U.S. FDA Accelerated Approval of Ipsen's Iqirvo® for Primary Biliary Cholangitis | 10.06.24
finanzen.at - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.at Daily Mail and Mail on Sunday newspapers.

Taiwan
Massachusetts
United-states
China
United-kingdom
Macau
Switzerland
Cambridge
Cambridgeshire
Paris
France-general
France

Ipsen's Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis | Company Announcement

Ipsen's Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis | Company Announcement
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

United-states
Macau
Paris
France-general
France
United-kingdom
China
Hong-kong
Washington
Taiwan
American
Ipsen-euronext

Ipsen Pharma: Ipsen's Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis

Iqirvo® (elafibranor) 80 mg tablets is the first new medicine approved in nearly a decade for the treatment of the rare liver

Paris
France-general
France
Macau
United-states
China
United-kingdom
Washington
Hong-kong
Taiwan
American
Christelle-huguet

Ipsen's Iqirvo® receives U.S. FDA accelerated approval as a

Ipsen's Iqirvo® receives U.S. FDA accelerated approval as a
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

Taiwan
Paris
France-general
France
United-states
Hong-kong
Washington
China
United-kingdom
Macau
American
Carol-roberts